17 C
Lucknow
Online Latest News Hindi News , Bollywood News

Advantage Health Care India 2016

Uncategorized

New Delhi: The successful launch of the inaugural edition last year, Department of Commerce, Government of India organized the second edition of ‘Advantage Health Care India 2016 (AHCI 2016)’, an International Summit on Medical Value Travel with the aim of ‘Promoting Healthcare Services Exports from India’, from 3 – 5 October, 2016 at India Expo Centre & Mart, Greater Noida, NCR – India.

The objective of this international summit was to promote India as a Premier Global Healthcare Destination and to enable streamlined medical services exports from India. This underlying objective is a unique conglomeration of 5Ts, namely – Tradition, Technology, Tourism, Talent and Trade.

AHCI 2016 brought together stakeholders from 67 countries. The Summit presented an opportunity to interact, network and collaborate through the hosted buyer’s program, the exhibition, the conference along with regional forums as well as visits to some of the world class hospitals in Delhi and NCR.

The medical value travel industry has emerged as one of the fastest growing segment of the tourism industry. Globally the market is estimated at around USD 40-55 billion. India has tremendous potential in MVT. Our estimated market size is USD 3 Billion, growing at 15% CAGR. As per 2015 data while 11 million people travelled to seek treatment, 500,000 foreign patients travelled to India seeking treatment. With adequate focus and effective execution, MVT in India can be a USD 9 billion opportunity by 2020.

The Summit helped in showcasing the medical healthcare sector in India and how we can collaborate with World. In addition, it showcased the training capabilities of India in Medical healthcare, AYUSH and Nursing sector. In addition, some tangible outcomes have emerged like streamlining the functioning of facilitators and acknowledging them as part of the MVT ecosystem, Implementation of Medical facilitation desks at airports for ease of medical patients and has generated interest even from markets like Russia and China.

This information was given by the Commerce and Industry Minister Smt. Nirmala Sitharaman in a written reply in Lok Sabha today.

Related posts

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More